Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Down Syndrome Clinical Trials Network (DS-CTN) Study of Alzheimer's Disease in Down Syndrome

NCT04149197 is registered in ClinicalTrials.gov with LuMind IDSC Foundation as lead sponsor.

NCT NCT04149197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04149197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Down Syndrome Clinical Trials Network (DS-CTN) Study of Alzheimer's Disease in Down Syndrome
Lead sponsor
LuMind IDSC Foundation
Phase
Observational
Overall status
Terminated
Start date
June 30, 2019
Completion date
April 17, 2024
Enrollment
252 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease in down syndrome